Dowling & Yahnke’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.72M | Sell |
33,674
-1,011
| -3% | -$90.9K | 0.13% | 149 |
|
|
2022
Q2 | $3.11M | Buy |
34,685
+433
| +1% | +$43.9K | 0.15% | 139 |
|
|
2022
Q1 | $3.8M | Buy |
34,252
+932
| +3% | +$98.5K | 0.17% | 135 |
|
|
2021
Q4 | $3.45M | Sell |
33,320
-1,624
| -5% | -$188K | 0.17% | 140 |
|
|
2021
Q3 | $4.38M | Buy |
34,944
+989
| +3% | +$128K | 0.24% | 110 |
|
|
2021
Q2 | $4.21M | Buy |
33,955
+905
| +3% | +$114K | 0.24% | 109 |
|
|
2021
Q1 | $3.9M | Buy |
33,050
+818
| +3% | +$95.9K | 0.27% | 104 |
|
|
2020
Q4 | $3.78M | Buy |
32,232
+31
| +0.1% | +$3.41K | 0.27% | 101 |
|
|
2020
Q3 | $3.35M | Buy |
32,201
+1,390
| +5% | +$140K | 0.27% | 106 |
|
|
2020
Q2 | $2.83M | Buy |
30,811
+2,913
| +10% | +$279K | 0.24% | 112 |
|
|
2020
Q1 | $2.52M | Sell |
27,898
-3,053
| -10% | -$325K | 0.24% | 114 |
|
|
2019
Q4 | $3.51M | Buy |
30,951
+964
| +3% | +$106K | 0.27% | 107 |
|
|
2019
Q3 | $3.26M | Buy |
29,987
+1,512
| +5% | +$158K | 0.27% | 107 |
|
|
2019
Q2 | $2.77M | Buy |
28,475
+743
| +3% | +$67.8K | 0.23% | 119 |
|
|
2019
Q1 | $2.53M | Buy |
27,732
+4,950
| +22% | +$443K | 0.24% | 108 |
|
|
2018
Q4 | $2.22M | Buy |
22,782
+2,245
| +11% | +$210K | 0.23% | 112 |
|
|
2018
Q3 | $2.02M | Sell |
20,537
-1,225
| -6% | -$113K | 0.18% | 145 |
|
|
2018
Q2 | $1.86M | Sell |
21,762
-1,277
| -6% | -$107K | 0.17% | 151 |
|
|
2018
Q1 | $1.85M | Sell |
23,039
-2,241
| -9% | -$185K | 0.17% | 145 |
|
|
2017
Q4 | $2.04M | Sell |
25,280
-1,036
| -4% | -$83K | 0.18% | 142 |
|
|
2017
Q3 | $2.05M | Sell |
26,316
-424
| -2% | -$35.2K | 0.21% | 135 |
|
|
2017
Q2 | $2.37M | Buy |
26,740
+628
| +2% | +$53K | 0.25% | 115 |
|
|
2017
Q1 | $2.1M | Sell |
26,112
-1,308
| -5% | -$102K | 0.22% | 124 |
|
|
2016
Q4 | $1.95M | Sell |
27,420
-1,226
| -4% | -$96.3K | 0.22% | 124 |
|
|
2016
Q3 | $2.48M | Sell |
28,646
-621
| -2% | -$54.1K | 0.29% | 108 |
|
|
2016
Q2 | $2.54M | Sell |
29,267
-692
| -2% | -$56K | 0.3% | 105 |
|
|
2016
Q1 | $2.25M | Sell |
29,959
-346
| -1% | -$26.1K | 0.28% | 106 |
|
|
2015
Q4 | $2.33M | Sell |
30,305
-3,836
| -11% | -$289K | 0.29% | 106 |
|
|
2015
Q3 | $2.29M | Sell |
34,141
-4,722
| -12% | -$348K | 0.31% | 103 |
|
|
2015
Q2 | $2.88M | Sell |
38,863
-7,095
| -15% | -$542K | 0.36% | 91 |
|
|
2015
Q1 | $3.58M | Sell |
45,958
-4,866
| -10% | -$369K | 0.45% | 77 |
|
|
2014
Q4 | $3.67M | Sell |
50,824
-680
| -1% | -$47.2K | 0.46% | 74 |
|
|
2014
Q3 | $3.19M | Sell |
51,504
-1,187
| -2% | -$75.5K | 0.42% | 81 |
|
|
2014
Q2 | $3.36M | Sell |
52,691
-103
| -0.2% | -$6.26K | 0.43% | 78 |
|
|
2014
Q1 | $3.25M | Buy |
52,794
+8,289
| +19% | +$483K | 0.43% | 76 |
|
|
2013
Q4 | $2.55M | Sell |
44,505
-813
| -2% | -$46.1K | 0.36% | 94 |
|
|
2013
Q3 | $2.41M | Sell |
45,318
-1,375
| -3% | -$74K | 0.38% | 90 |
|
|
2013
Q2 | $2.4M | Buy |
+46,693
| New | +$2.31M | 0.4% | 85 |
|
Other funds holding MDT
Dowling & Yahnke's MDT Position: Q3 2022 in Review
Dowling & Yahnke reduced its Medtronic (MDT) stake by 2.9% in Q3 2022, selling an estimated $90.9K and leaving 33,674 shares worth $2.72M. The position accounts for 0.13% of the portfolio, ranked #149.
Dowling & Yahnke first reported a position in MDT in Q2 2013 and has held it in 38 quarters since. The position peaked at $4.38M in Q3 2021. 1,931 funds tracked by Wall St. Rank hold MDT as of Q3 2022.
- Dowling & Yahnke held 33,674 shares of Medtronic worth $2.72M as of Q3 2022.
- Dowling & Yahnke sold 1,011 Medtronic shares in Q3 2022, an estimated $90.9K.
- Medtronic made up 0.13% of Dowling & Yahnke's portfolio in Q3 2022, its #149 holding.
- Dowling & Yahnke first reported a position in Medtronic in Q2 2013 and has held it in 38 quarters since.
- Dowling & Yahnke's Medtronic position peaked at $4.38M in Q3 2021.
- 1,931 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.
Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.